In a major medical breakthrough, the US FDA has approved a new oral drug for Thalassemia, offering hope for a transfusion-free life. Discussing the development, Dr Sanjeev Bagai, Chairman of Nephron Clinic, states that the drug ‘would definitely be a game changer’ as it addresses the root cause of beta protein dysfunction. Currently, patients face lifelong challenges with regular blood transfusions, iron overload, and chelation therapy. Dr Bagai highlights that the new oral medication could improve quality of life and reduce costs. Regarding availability in India, he estimates a timeline of six to nine months, pending local trials by the ICMR.
#Thalassemia #FDAApproval #MedicalBreakthrough #itwebvideos #DrSanjeevBagai #HealthNews #IndiaToday #OralDrug #Anemia #BloodDisorder #Healthcare #Medicine #Science #TransfusionFree #PublicHealth #ICMR
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you’ll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India’s leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.
Stay tuned for latest updates and in-depth analysis of news from India and around the world!
WhatsApp Channel: https://whatsapp.com/channel/0029Va2AnW3JENxxg7OuJv00
Download App: https://indiatoday.link/wHaj
Follow us: Official website: https://www.indiatoday.in/
Twitter: https://twitter.com/IndiaToday
Facebook: https://www.facebook.com/IndiaToday
